After India and China completed their disengagement process in one part of border territory in Leh Ladakh, US State Department spokesperson Ned Price said that the United States welcomes the ongoing efforts to deescalate the situation and will continue to monitor the situation closely as both sides work toward a peaceful resolution.
At a press briefing, Price said, "We are closely following reports of troop disengagement and we welcome the ongoing efforts to deescalate the situation. We will continue to monitor the situation closely as both sides work toward a peaceful resolution."
When asked about India and US coordination on COVID-19 vaccines, Price said, "India and US build on decades of successful partnership and health and by the medical research, we are partnering to strengthen the global response to COVID-19."
"US and India recently welcomed an initiative to collaborate through an international center of excellence in research focused on infectious disease including Covid and we look forward to an overarching memorandum of understanding (MoU) to enhance health cooperation," he said.
Price further said that US and India are working together on developing diagnostics therapeutics vaccines to combat the disease and to recognise the importance of manufacturing critical drugs during this time and making them accessible globally.
"India's pharmaceutical sector is strong and well-established and has long played a central role in manufacturing life-saving vaccines for global use. We are pleased that the US pharmaceutical industry has been coordinating with the Indian pharma industry since the beginning of the COVID-19 pandemic," he added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU